Consumer advocate: Even relatively minor drug-related interactions can still be harmful to patients. For example, aspirin taken with fruit juice is ineffective. People unaware of this suffer unnecessary discomfort or take more aspirin than necessary. The government should, therefore, require drug companies to notify consumers of all known drug-related interactions.
Which one of the following, if true, most weakens the consumer advocate's argument?The advocate argues that consumers should be told about all known drug-related interactions because even minor interactions can harm patients.
The best weakener should show that giving information about all interactions may make patients less safe, especially by distracting them from
serious interactions.
(A) Providing information on minor drug-related interactions would detract from a patient's attention to serious interactions.
This is correct. If listing minor interactions makes patients pay less attention to serious ones, then requiring notice of all interactions could be harmful rather than helpful.
(B) Many drugs have fewer documented drug-related interactions than does aspirin.
This does not weaken the argument. Even if some drugs have fewer interactions, the advocate could still say consumers should be informed about all known ones.
(C) Providing information about all drug-related interactions would result in only negligible price increases for consumers.
This strengthens, or at least does not weaken, the argument. It removes a possible cost objection.
(D) Current research is such that many drug-related interactions have not yet been identified.
This does not weaken the recommendation to disclose known interactions. The advocate is not saying companies should disclose unknown interactions.
(E) Pharmacists usually draw patients' attention to printed warnings that are provided with drugs.
This does not weaken the argument. It may support printed warnings by showing that patients are likely to notice them.
Answer: (A)